Sector: MedicalAngiotech Pharmaceuticals, Inc. (NASDAQ: ANPI)
Ranking History
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 293 |
Technical : | 301 |
Performance : | 282 |
Overall: | 304 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 295 |
Technical : | 275 |
Performance : | 290 |
Overall: | 304 |
Number of Stocks: | 306 |
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 293 |
Technical : | 288 |
Performance : | 276 |
Overall: | 305 |
Number of Stocks: | 306 |
Headlines
- Bullish Monday for TSX
Nov 09, 2009 10:09 AM | ANPI, CMCSA, ESI, GE, GIB
- Angiotech Pharmaceuticals, Inc. announces financial results for the third quarter ended September 30, 2009
Nov 09, 2009 07:09 AM | ANPI, BSX
- Angiotech Pharmaceuticals announces commercial launch of the Tan Endoglide(TM) Endothelium Insertion System in the United States at the American Academy of Ophthalmology annual meeting
Oct 23, 2009 09:04 AM | ANPI
- BioMed News Bytes: Angiotech, BioSante, HGSI
Oct 20, 2009 11:55 AM | AIS, ANPI, GSK, HGSI, SLE
- Angiotech Pharmaceuticals provides update on Bio-Seal(TM) 510(K) submission
Oct 19, 2009 04:31 PM | ANPI
- Angiotech Pharmaceuticals, Inc. Announces Conference Call and Webcast
Oct 09, 2009 12:36 PM | ANPI
- Angiotech Pharmaceuticals announces TAXUS(R) Liberté(R) Stent continues to demonstrate significant improvements over TAXUS(R) Express(R) Stent in small vessels and long lesions
Sep 22, 2009 02:21 PM | ANPI, BSX
- Angiotech Pharmaceuticals announces TAXUS(R) Liberte(R) Stent continues to demonstrate significant improvements over TAXUS(R) Express(R) Stent in small vessels and long lesions
Sep 22, 2009 02:20 PM | ANPI, BSX
- Haemacure fait rapport sur ses activités et annonce les résultats du troisième trimestre de 2009
Sep 14, 2009 12:33 PM | ANPI, HAE
- Haemacure Reports on Current Activities and Third Quarter 2009 Financial Results
Sep 14, 2009 12:30 PM | ANPI, HAE
- Angiotech's corporate partner, Boston Scientific, reports two-year SYNTAX data showing comparable safety outcomes for complex patients treated with Taxus(R) Express(R) stents and bypass surgery
Sep 02, 2009 03:30 PM | ANPI
- Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States
Aug 20, 2009 08:31 AM | ANPI
- Angiotech's Licensee, Cook Medical, Announces CE Mark Approval and European Launch of the Zilver(R) PTX(R) Stent
Aug 11, 2009 08:00 AM | ANPI
- Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
Aug 06, 2009 08:31 AM | ANPI
- Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures
Aug 04, 2009 08:30 AM | ANPI
- Angiotech Pharmaceuticals announces FDA approval of TAXUS(R) Liberte(R) Long Stent
Jul 16, 2009 12:51 PM | ANPI
- Angiotech Pharmaceuticals, Inc. announces conference call and webcast
Jul 06, 2009 08:30 AM | ANPI
- Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter
Jun 08, 2009 08:30 AM | ANPI
- Angiotech Pharmaceuticals announces FDA approval of next-generation TAXUS(R) Liberte(R) Atom(TM) Stent system
May 27, 2009 11:55 AM | ANPI
- SYNTAX analysis finds treatment with TAXUS(R) Express(2)(R) Stent System more cost effective than bypass surgery in patients with complex coronary artery disease system
May 20, 2009 02:11 PM | ANPI
- Form 4 ANGIOTECH PHARMACEUTICAL For: Nov 11 Filed by: Cunliffe Sean (10K)
Nov 12, 2009 05:46 PM
- Form 4 ANGIOTECH PHARMACEUTICAL For: Sep 29 Filed by: Hunter William L (10K)
Sep 30, 2009 04:35 PM
- Form 3 ANGIOTECH PHARMACEUTICAL For: Sep 08 Filed by: Cunliffe Sean (10K)
Sep 14, 2009 06:21 PM
- Form 4/A ANGIOTECH PHARMACEUTICAL For: Aug 27 Filed by: Gross Jeffrey M (10K)
Aug 31, 2009 09:42 PM
- Form 4 ANGIOTECH PHARMACEUTICAL For: Aug 27 Filed by: Gross Jeffrey M (10K)
Aug 31, 2009 03:27 PM
- Form 4 ANGIOTECH PHARMACEUTICAL For: Aug 17 Filed by: Bailey K Thomas (10K)
Aug 19, 2009 06:24 PM
- Form 4 ANGIOTECH PHARMACEUTICAL For: Aug 14 Filed by: Neske Tammy (10K)
Aug 14, 2009 07:03 PM
- Form 4 ANGIOTECH PHARMACEUTICAL For: Aug 13 Filed by: Dent Jay Bernard (10K)
Aug 14, 2009 06:45 PM
- Form 4 ANGIOTECH PHARMACEUTICAL For: Aug 12 Filed by: Willms Arthur H (10K)
Aug 13, 2009 02:30 PM
- Form 4 ANGIOTECH PHARMACEUTICAL For: Aug 12 Filed by: Chen Jonathan W (10K)
Aug 13, 2009 02:25 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
ANPI
|
Compare to S&P
|
| YTD |
403.85 %
|
316.19 %
|
| 4 Weeks |
-22.02 %
|
-22.44 %
|
| 12 Weeks |
-25.14 %
|
-29.75 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 100.00 %
|
|
EPS Growth in Last Year: 100.00 %
|
|
Sales Growth in Last Quarter: -2.06 %
|
|
Sales Growth in Last Quarter: -7.48 %
|
|
